NCT00873210View on ClinicalTrials.gov

Study In Patients With Kidney Cancer Treated With Sutent

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Advanced or Metastatic Renal Cell CarcinomaRenal Cancer
Interventions
DRUG

Sutent

50 mg per day for 4 consecutive weeks, followed by 2 weeks treatment pause

Trial Locations (14)

975 17

Pfizer Investigational Site, Banská Bystrica

972 01

Pfizer Investigational Site, Bojnice

812 50

Pfizer Investigational Site, Bratislava

833 10

Pfizer Investigational Site, Bratislava

043 91

Pfizer Investigational Site, Košice

071 01

Pfizer Investigational Site, Michalovce

949 01

Pfizer Investigational Site, Nitra

058 01

Pfizer Investigational Site, Poprad

081 81

Pfizer Investigational Site, Prešov

034 26

Pfizer Investigational Site, Ružomberok

075 01

Pfizer Investigational Site, Trebišov

911 71

Pfizer Investigational Site, Trenčín

917 75

Pfizer Investigational Site, Trnava

012 07

Pfizer Investigational Site, Žilina

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY